drugset / Trial / NCT07682948

A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy Volunteers

NCT07682948 ↗

Phase 1 Recruiting 36 enrolled Korea United Pharm. Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy Volunteers

Timeline

Start
2026-07-01
Primary completion
2026-09
Completion
2026-09

Drugs

EvaluationDrugModalityDoseRoute
Subject UIC202601 Unknown 1 unknown —
Subject UIC202602 Unknown 1 unknown —